ROTHBLATT MARTINE A sold UTHR
October 31, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 537 shares of United Therapeutics Corporation at $449.83 per share, a transaction worth $241.6K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
537
Price
$449.83
Total value
$241.6K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 31, 2025
Filing dateNovember 4, 2025
Shares owned after2,593
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.